Enzyme therapy for Fabry disease: neutralizing antibodies toward agalsidase alpha and beta.
Linthorst GE; Hollak CE; Donker-Koopman WE; Strijland A; Aerts JM; Kidney International, 2004, vol. 66, issue 4, p 1589, ISSN 00852538. ISBN 00852538.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef